Shilpa Medicare Limited
NSE:SHILPAMED.NS
852 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Shilpa Medicare Limited |
Symbool | SHILPAMED.NS |
Munteenheid | INR |
Prijs | 852 |
Beurswaarde | 83,317,846,800 |
Dividendpercentage | 0% |
52-weken bereik | 313.15 - 959.5 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Vishnukanth Chaturbhuj Bhutada B. Pharm |
Website | https://www.vbshilpa.com |
An error occurred while fetching data.
Over Shilpa Medicare Limited
Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (API's), intermediates, and formulations in India, the United States, Europe, and internationally. It offers oncology and non-oncology API's.; and new drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company also provides contract manufacturing
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)